Nektar Therapeutics
NASDAQ:NKTR

Watchlist Manager
Nektar Therapeutics Logo
Nektar Therapeutics
NASDAQ:NKTR
Watchlist
Price: 1.17 USD -8.59% Market Closed
Market Cap: 215.4m USD
Have any thoughts about
Nektar Therapeutics?
Write Note

Nektar Therapeutics
Accumulated Depreciation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nektar Therapeutics
Accumulated Depreciation Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors

Company Accumulated Depreciation CAGR 3Y CAGR 5Y CAGR 10Y
Nektar Therapeutics
NASDAQ:NKTR
Accumulated Depreciation
-$88.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Accumulated Depreciation
-$28.8B
CAGR 3-Years
0%
CAGR 5-Years
-2%
CAGR 10-Years
-3%
Bristol-Myers Squibb Co
NYSE:BMY
Accumulated Depreciation
-$4.8B
CAGR 3-Years
-7%
CAGR 5-Years
-4%
CAGR 10-Years
-1%
Pfizer Inc
NYSE:PFE
Accumulated Depreciation
-$16.6B
CAGR 3-Years
-2%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Accumulated Depreciation
-$19.1B
CAGR 3-Years
-2%
CAGR 5-Years
-2%
CAGR 10-Years
0%
Eli Lilly and Co
NYSE:LLY
Accumulated Depreciation
-$11.8B
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
-4%

See Also

What is Nektar Therapeutics's Accumulated Depreciation?
Accumulated Depreciation
-88.4m USD

Based on the financial report for Jun 30, 2024, Nektar Therapeutics's Accumulated Depreciation amounts to -88.4m USD.

What is Nektar Therapeutics's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 1Y
18%

Over the last year, the Accumulated Depreciation growth was 18%.

Back to Top